Literature DB >> 28390775

Deep Transcranial Magnetic Stimulation of the Dorsolateral Prefrontal Cortex in Alcohol Use Disorder Patients: Effects on Dopamine Transporter Availability and Alcohol Intake.

Giovanni Addolorato1, Mariangela Antonelli2, Fabrizio Cocciolillo3, Gabriele A Vassallo2, Claudia Tarli2, Luisa Sestito2, Antonio Mirijello4, Anna Ferrulli5, Daniele A Pizzuto3, Giovanni Camardese6, Antonio Miceli7, Marco Diana8, Alessandro Giordano3, Antonio Gasbarrini9, Daniela Di Giuda3.   

Abstract

Repetitive Transcranial Magnetic Stimulation (rTMS) of the dorsolateral prefrontal cortex may affect neuro-adaptations associated with alcohol use disorder (AUD), potentially influencing craving and alcohol intake. We investigated alcohol intake and dopamine transporter (DAT) availability by Single Photon Emission Computed Tomography (SPECT) in the striatum of AUD patients before and after deep rTMS. Fourteen patients underwent baseline clinical and SPECT assessment. Eleven out of fourteen patients were randomized into two groups for the REAL (n.5) or SHAM (n.6) treatment. Clinical and SPECT evaluations were then carried out after four weeks of rTMS sessions (T1). At baseline, AUD patients showed higher striatal DAT availability than healthy control subjects (HC). Patients receiving the REAL stimulation revealed a reduction in DAT availability at T1, whereas the SHAM-treated group did not. In addition, patients receiving the REAL stimulation had a decrease in alcohol intake. The results of this longitudinal pilot study may suggest a modulatory effect of deep rTMS on dopaminergic terminals and a potential clinical efficacy in reducing alcohol intake in AUD patients. Further investigations are required to confirm these preliminary data.
Copyright © 2017 Elsevier B.V. and ECNP. All rights reserved.

Entities:  

Keywords:  (123)I-FP-CIT; Alcohol dependence; Dopamine transporter; Dorsolateral prefrontal cortex; Single photon emission computed tomography; Transcranial magnetic stimulation

Mesh:

Substances:

Year:  2017        PMID: 28390775     DOI: 10.1016/j.euroneuro.2017.03.008

Source DB:  PubMed          Journal:  Eur Neuropsychopharmacol        ISSN: 0924-977X            Impact factor:   4.600


  15 in total

1.  High frequency deep transcranial magnetic stimulation acutely increases β-endorphins in obese humans.

Authors:  Anna Ferrulli; Concetta Macrì; Ileana Terruzzi; Federico Ambrogi; Valentina Milani; Michela Adamo; Livio Luzi
Journal:  Endocrine       Date:  2018-11-08       Impact factor: 3.633

Review 2.  Transcranial magnetic stimulation, deep brain stimulation, and other forms of neuromodulation for substance use disorders: Review of modalities and implications for treatment.

Authors:  James J Mahoney; Colleen A Hanlon; Patrick J Marshalek; Ali R Rezai; Lothar Krinke
Journal:  J Neurol Sci       Date:  2020-09-20       Impact factor: 3.181

Review 3.  Rehabilitating the addicted brain with transcranial magnetic stimulation.

Authors:  Marco Diana; Tommi Raij; Miriam Melis; Aapo Nummenmaa; Lorenzo Leggio; Antonello Bonci
Journal:  Nat Rev Neurosci       Date:  2017-09-29       Impact factor: 34.870

Review 4.  New steps for treating alcohol use disorder.

Authors:  Erin J Campbell; Andrew J Lawrence; Christina J Perry
Journal:  Psychopharmacology (Berl)       Date:  2018-03-25       Impact factor: 4.530

5.  Transcranial electrical and magnetic stimulation (tES and TMS) for addiction medicine: A consensus paper on the present state of the science and the road ahead.

Authors:  Hamed Ekhtiari; Hosna Tavakoli; Giovanni Addolorato; Chris Baeken; Antonello Bonci; Salvatore Campanella; Luis Castelo-Branco; Gaëlle Challet-Bouju; Vincent P Clark; Eric Claus; Pinhas N Dannon; Alessandra Del Felice; Tess den Uyl; Marco Diana; Massimo di Giannantonio; John R Fedota; Paul Fitzgerald; Luigi Gallimberti; Marie Grall-Bronnec; Sarah C Herremans; Martin J Herrmann; Asif Jamil; Eman Khedr; Christos Kouimtsidis; Karolina Kozak; Evgeny Krupitsky; Claus Lamm; William V Lechner; Graziella Madeo; Nastaran Malmir; Giovanni Martinotti; William M McDonald; Chiara Montemitro; Ester M Nakamura-Palacios; Mohammad Nasehi; Xavier Noël; Masoud Nosratabadi; Martin Paulus; Mauro Pettorruso; Basant Pradhan; Samir K Praharaj; Haley Rafferty; Gregory Sahlem; Betty Jo Salmeron; Anne Sauvaget; Renée S Schluter; Carmen Sergiou; Alireza Shahbabaie; Christine Sheffer; Primavera A Spagnolo; Vaughn R Steele; Ti-Fei Yuan; Josanne D M van Dongen; Vincent Van Waes; Ganesan Venkatasubramanian; Antonio Verdejo-García; Ilse Verveer; Justine W Welsh; Michael J Wesley; Katie Witkiewitz; Fatemeh Yavari; Mohammad-Reza Zarrindast; Laurie Zawertailo; Xiaochu Zhang; Yoon-Hee Cha; Tony P George; Flavio Frohlich; Anna E Goudriaan; Shirley Fecteau; Stacey B Daughters; Elliot A Stein; Felipe Fregni; Michael A Nitsche; Abraham Zangen; Marom Bikson; Colleen A Hanlon
Journal:  Neurosci Biobehav Rev       Date:  2019-07-02       Impact factor: 8.989

Review 6.  A review of brain stimulation methods to treat substance use disorders.

Authors:  Alexandria S Coles; Karolina Kozak; Tony P George
Journal:  Am J Addict       Date:  2018-02-19

7.  Deep Transcranial Magnetic Stimulation Affects Gut Microbiota Composition in Obesity: Results of Randomized Clinical Trial.

Authors:  Anna Ferrulli; Lorenzo Drago; Sara Gandini; Stefano Massarini; Federica Bellerba; Pamela Senesi; Ileana Terruzzi; Livio Luzi
Journal:  Int J Mol Sci       Date:  2021-04-29       Impact factor: 5.923

Review 8.  Transcranial magnetic stimulation for the treatment of cocaine addiction: evidence to date.

Authors:  Corinna Bolloni; Paola Badas; Giorgio Corona; Marco Diana
Journal:  Subst Abuse Rehabil       Date:  2018-05-21

9.  Can deep transcranial magnetic stimulation (DTMS) be used to treat substance use disorders (SUD)? A systematic review.

Authors:  Karina Karolina Kedzior; Imke Gerkensmeier; Maria Schuchinsky
Journal:  BMC Psychiatry       Date:  2018-05-18       Impact factor: 3.630

10.  The effects of repetitive transcranial magnetic stimulation on cue-induced craving in male patients with heroin use disorder.

Authors:  Xiaoli Liu; Xiwen Zhao; Ting Liu; Qingming Liu; Li Tang; Hui Zhang; Wenbo Luo; Zafiris J Daskalakis; Ti-Fei Yuan
Journal:  EBioMedicine       Date:  2020-06-05       Impact factor: 8.143

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.